489 related articles for article (PubMed ID: 31395480)
1. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
[TBL] [Abstract][Full Text] [Related]
2. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.
Ehdaie B; Furberg H; Zabor EC; Ostroff JS; Shariat SF; Bochner BH; Coleman JA; Dalbagni G
BJU Int; 2013 Apr; 111(4):589-95. PubMed ID: 22642265
[TBL] [Abstract][Full Text] [Related]
3. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
Xylinas E; Kluth LA; Rieken M; Lee RK; Elghouayel M; Ficarra V; Margulis V; Lotan Y; Rouprêt M; Martinez-Salamanca JI; Matsumoto K; Seitz C; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF;
BJU Int; 2014 Jul; 114(1):56-61. PubMed ID: 24053463
[TBL] [Abstract][Full Text] [Related]
4. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
Rink M; Xylinas E; Margulis V; Cha EK; Ehdaie B; Raman JD; Chun FK; Matsumoto K; Lotan Y; Furberg H; Babjuk M; Pycha A; Wood CG; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF;
Eur Urol; 2013 Jun; 63(6):1082-90. PubMed ID: 22743166
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
[TBL] [Abstract][Full Text] [Related]
6. Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.
Martini A; Lonati C; Nocera L; Fallara G; Raggi D; Herout R; Zamboni S; Ploussard G; Predere B; Mattei A; Simeone C; Krajewski W; Simone G; Soria F; Gontero P; Roupret M; Montorsi F; Briganti A; Shariat SF; Necchi A; Moschini M
Eur Urol Oncol; 2022 Aug; 5(4):451-459. PubMed ID: 35504834
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
Jiang Y; Yao Z; Zhu X; Wu B; Bai S
Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
[TBL] [Abstract][Full Text] [Related]
8. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
Rink M; Xylinas E; Trinh QD; Lotan Y; Margulis V; Raman JD; Fisch M; Lee RK; Chun FK; Abdennabi J; Seitz C; Pycha A; Zlotta AR; Karakiewicz PI; Babjuk M; Scherr DS; Shariat SF;
BJU Int; 2013 Sep; 112(5):623-37. PubMed ID: 23465088
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
11. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
[TBL] [Abstract][Full Text] [Related]
12. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
[TBL] [Abstract][Full Text] [Related]
13. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
[TBL] [Abstract][Full Text] [Related]
14. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
[TBL] [Abstract][Full Text] [Related]
15. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074
[TBL] [Abstract][Full Text] [Related]
17. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
[TBL] [Abstract][Full Text] [Related]
18. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
19. Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.
Sevillano E; Werner L; Bossé D; Lalani AA; Wankowicz SAM; de Velasco G; Farina M; Lundgren K; Choueiri TK; González Del Alba A; Bellmunt J
Clin Genitourin Cancer; 2017 Dec; 15(6):e1089-e1094. PubMed ID: 28864222
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.
Seisen T; Granger B; Colin P; Léon P; Utard G; Renard-Penna R; Compérat E; Mozer P; Cussenot O; Shariat SF; Rouprêt M
Eur Urol; 2015 Jun; 67(6):1122-1133. PubMed ID: 25488681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
